US Physical Therapy Inc

U.S. Physical Therapy, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurological-related injuries and rehabilitation of injured workers. The company operates through subsidiary clinic partnerships. To a lesser extent, the company operates some clinics through wholly-owned subsidiaries under profit sharing arrangements with therapists. The company has a majority interest in a company, which is a provider of industrial injury prevention. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.
  • TickerUSPH
  • ISINUS90337L1089
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States
Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Breakout Brewing? With the 3200-3230 support level holding strong on the S&P 500, we remain constructive over the intermediate-term as outlined in our 11/3/20 Compass. Considering current market dynamics we see eventual decisive breakouts as the most likely outcome for the major averages, which justifies our positive outlook. At the same time, with the S&P 500, Russell 2000, and Nasdaq 100 climbing 7-12% in just over a week and all three testing logical resistance, we believe there is potential for some near-term backing-and-filling. Continue to buy dips. · Testing Resistance. Both t...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Valens Research

UAFRS vs As Reported Weekly Highlights - 2020 03 26

This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for USPH, MEDP, and WES.

Dave Nicoski ...
  • Ross LaDuke

Insights: Bullish Health Care Stocks

Attractive opportunities within Health Care Services -- buy DXCM and USPH Stocks within Health Care Services continue to offer attractive and timely buy opportunities. The combination of having defensive characteristics (low earnings cyclicality), generally being unaffected by the ongoing U.S.-China trade war, and the timeliness of bullish price and RS inflections create what we believe is a compelling case to add exposure to DXCM and USPH at current levels. • DexCom, Inc. (DXCM): DexCom designs and sells continuous glucose monitoring systems for diabetics - an alternative to the tradition...

Dave Nicoski ...
  • Ross LaDuke

Insights: Bullish Health Care Stocks

Attractive opportunities within Health Care Services -- buy DXCM and USPH Stocks within Health Care Services continue to offer attractive and timely buy opportunities. The combination of having defensive characteristics (low earnings cyclicality), generally being unaffected by the ongoing U.S.-China trade war, and the timeliness of bullish price and RS inflections create what we believe is a compelling case to add exposure to DXCM and USPH at current levels. • DexCom, Inc. (DXCM): DexCom designs and sells continuous glucose monitoring systems for diabetics - an alternative to the tradition...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Breakout Brewing? With the 3200-3230 support level holding strong on the S&P 500, we remain constructive over the intermediate-term as outlined in our 11/3/20 Compass. Considering current market dynamics we see eventual decisive breakouts as the most likely outcome for the major averages, which justifies our positive outlook. At the same time, with the S&P 500, Russell 2000, and Nasdaq 100 climbing 7-12% in just over a week and all three testing logical resistance, we believe there is potential for some near-term backing-and-filling. Continue to buy dips. · Testing Resistance. Both t...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Valens Research

UAFRS vs As Reported Weekly Highlights - 2020 03 26

This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for USPH, MEDP, and WES.

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch